Boxer Capital Management’s iTeos Therapeutics ITOS Stock Holding History

Boxer Capital Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-825,000	Closed	-$8.23M	–	35
2025 Q2	$8.23M	Buy	+825,000	New	+$6.65M	4.14%	7
2025 Q1	–	Sell	-946,915	Closed	-$7.27M	–	40
2024 Q4	$7.27M	Buy	+946,915	New	+$8.14M	0.62%	35

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Boxer Capital Management's ITOS Position: Q3 2025 in Review

Boxer Capital Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 825,000 shares — an estimated $8.23M sold.

Boxer Capital Management first reported a position in ITOS in Q4 2024 and held it in 2 quarters. The position peaked at $8.23M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Boxer Capital Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Boxer Capital Management sold 825,000 iTeos Therapeutics shares in Q3 2025, an estimated $8.23M.
Boxer Capital Management first reported a position in iTeos Therapeutics in Q4 2024 and held it in 2 quarters.
Boxer Capital Management's iTeos Therapeutics position peaked at $8.23M in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Boxer Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.